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Amphetamine, catatonic 
depression, and heart 
transplant: a case report
Anfetamina, depressão 
catatônica e transplante 
cardíaco: relato de caso
Dear Editor, 
Antidepressant treatments may take a few weeks to become effective 
and few quick-response alternatives are available. It has been proposed 
that methylphenidate can lead to a faster antidepressant response 
compared to the classic antidepressant drugs.1 This is a relevant 
proposition, particularly in cases in which life is threatened by a 
depressive state, as is the case presented bellow.
FT, a 55-year old male who underwent a heart transplant surgery 
due to heart failure secondary to Chagas cardiomyopathy. After the 
surgery, the patient reported feelings of sadness and hopelessness, 
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thus leading cardiologists to introduce sertraline 50mg/day on the 
8th post-operative (post-op) day (Figure 1). Nonetheless, the patient 
suddenly became completely unresponsive to commands, which 
made it necessary for him to be urgently seen by a psychiatrist. The 
psychiatric examination revealed a passive negativistic behavior, lack 
of eye contact, certain stereotyping, and refusal to respond to any 
sort of communication attempts (Hamilton Depression Hating 
Scale [HAM-D] 31 items = 32) - items that could not be assessed 
due to the catatonic state were scored as zero. The previous reference 
to sadness and hopelessness suggested a catatonic depressive episode. 
Since the cardiologists in charge were concerned that the patient 
could even die if respiratory physiotherapy was not included in the 
treatment plan, a more aggressive intervention was implemented 
using methylphenidate (up to 10mg/day; Figure 1). Four days 
later, the patient’s improvement was obvious. He was still rather 
sluggish but completely responsive to commands and oriented in 
time and space. No significant changes in hemodynamics were 
observed after the administration of methylphenidate. From that 
point on, improvement picked up speed. Antidepressant therapeutic 
response was objectively measured for the first time on the 23rd 
post op (HAM-D = 15) and full remission was attained on the 
37th post-op (HAM-D = 8) - items excluded in the first assessment 
were included in these last two assessments. Methylphenidate was 
discontinued on the 24th post op.
This case provides evidence that supports the adoption of brief 
low-dose interventions based on methylphenidate for heart-
transplanted patients with catatonic depression. Psychostimulants 
have already been proposed as a possible treatment for catatonic 
depression2 and depression associated with medical illnesses.3 
However, the safety of amphetamines, especially with respect 
to the cardiovascular system undermine the adoption of such 
approach.4,5 
The patient’s clinical conditions during the catatonic state 
remained stable. Even so, other causes for the catatonic state such 
as the medications used and surgery itself, as well as the causes 
for the improvement seen i.e., the administration of sertraline or 
the effect of time cannot be ruled out. While further controlled 
studies are not available, it is recommended that the approach 
herein described be limited in terms of length of time and that it 
be carefully monitored. 
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